A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

Clinical trial NCT01395004 · COMPLETED

Trial details

NCT number: NCT01395004
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Langerhans Cell Histiocytosis

Start date: 2011-11-01
Primary completion: 2013-11-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.